SPI Digital Health: With Consent Decree in Hand, What Now for Philips’ Ventilators?

Publication Date: 10/05/2024

Written by

Mark Lazell headshot
Mark Lazell

Philips has reached a final agreement with the US Department of Justice (DoJ) and FDA on a consent decree relating to its subsidiary Philips Respironics. Having already done hard yards to get to this stage, the company has plenty more work ahead of it.

The insight is part of Signify Research's Premium Insight – Digital Health subscription service.

To view the full insight on this development hit the Request Access button above for either a complimentary one month trial or to purchase a subscription. 

The Signify Research's Premium Insight – Digital Health subscription service provides:

  • Approximately 100 actionable and up to the moment Premium Insights per year.
  • A subscription to Signify Premium Insights – Digital Health provides compelling thought leadership on the most pertinent developments in healthcare technology.
  • This service utilises Signify Research’s expansive market data to properly appraise and interpret breaking news stories.
  • Major market moves and industry-changing announcements are evaluated as they unfold, and the considered opinions of Signify Research’s expert analysts are shared to provide insight into current developments.
  • Key vendors, technologies and conferences are followed, with updates carefully scrutinised to ensure that the most important details are revealed and properly assessed.